AI \u542b\u3080\u6700\u65b0\u88fd\u85ac DX \u3092\u7d39\u4ecb\u3000\u5148\u9032\u4e8b\u4f8b 10 \u793e\u767b\u58c7\u3082<\/p>\n
<\/p>\n
2025 \u5e74 9 \u6708 18 \u65e5
\nVeeva Japan \u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
\u65b0\u85ac\u306e\u81e8\u5e8a\u8a66\u9a13\u304b\u3089\u5e02\u8ca9\u5f8c\u307e\u3067\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306e\u696d\u52d9\u3092\u4e00\u6c17\u901a\u8cab\u3067\u652f\u3048\u308b SaaS \u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u4e16\u754c\u7684\u30d1\u30a4\u30aa\u30cb\u30a2\u3001\u7c73\u56fd Veeva Systems \u306e\u65e5\u672c\u6cd5\u4eba\u3067\u3042\u308b Veeva Japan\u682a\u5f0f\u4f1a\u793e\uff08\u672c\u793e\uff1a\u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u4ee3\u8868\u53d6\u7de0\u5f79\uff1a \u30af\u30ea\u30b9\u30fb\u30c0\u30a4\u30a2\u30e2\u30f3\u30c9\u3001\u4ee5\u4e0b Veeva Japan \uff09\u306f\u3001\u88fd\u85ac\u4f01\u696d\u306e R&D\u3001Quality \u90e8\u9580\u306b\u304a\u3051\u308b\u88fd\u85ac DX \u3084\u6700\u65b0\u30c8\u30ec\u30f3\u30c9\u3092\u7d39\u4ecb\u3059\u308b\u696d\u754c\u6700\u5927\u898f\u6a21\u306e\u30ea\u30a2\u30eb\u30a4\u30d9\u30f3\u30c8\u300c 2025 Veeva R&D and Quality Summit<\/a> \u300d\u3092\u300110 \u6708 9 \u65e5\uff08\u6728\uff09\u306b\u30d1\u30ec\u30b9\u30db\u30c6\u30eb\u6771\u4eac\u3067\u958b\u50ac\u3057\u307e\u3059\u3002<\/p>\n \u958b\u50ac 12 \u56de\u76ee\u3068\u306a\u308b\u4eca\u5e74\u306f\u3001\u56fd\u5185\u5916\u306e\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u7d04 10 \u793e\u304c\u767b\u58c7\u3002AI \u95a2\u9023\u306e\u6700\u65b0\u30a2\u30ca\u30a6\u30f3\u30b9\u30e1\u30f3\u30c8\u3092\u884c\u3046\u307b\u304b\u3001Clinical Operations\u3001Clinical Data\uff08\u3044\u305a\u308c\u3082\u4e3b\u306b\u81e8\u5e8a\u8a66\u9a13\u95a2\u9023\uff09\u3001Regulatory\uff08\u85ac\u4e8b\uff09\u3001Quality\uff08\u54c1\u8cea\u7ba1\u7406\uff09\u3001Safety\uff08\u5b89\u5168\u6027\u60c5\u5831\uff09\u306e 5 \u90e8\u9580\u306b\u5206\u304b\u308c\u3001\u5148\u9032\u9867\u5ba2\u4e8b\u4f8b\u306a\u3069\u3092\u3054\u7d39\u4ecb\u3057\u307e\u3059\u3002<\/p>\n \u226a\u6ce8\u76ee\u30b3\u30f3\u30c6\u30f3\u30c4\u226b<\/strong><\/p>\n \u25a0 Veeva Opening Keynote \u25a0 Session : \u4e2d\u5916\u88fd\u85ac\u306b\u304a\u3051\u308b Veeva Clinical \u5c0e\u5165 \u301c\u4e2d\u5916\u306e\u201c\u4e2d\u201d\u3068\u201c\u5916\u201d\u3092\u632f\u308a\u8fd4\u3063\u3066\u307f\u305f\u301c \u25a0 Session : Veeva Safety \u304c\u62d3\u304f\u3001AI\u3068\u81ea\u52d5\u5316\u306b\u3088\u308b\u5b89\u5168\u6027\u696d\u52d9\u306e\u672a\u6765 <\/p>\n \u201c 2025 Veeva R&D and Quality Summit \u201d \u958b\u50ac\u6982\u8981<\/strong> <\/p>\n \u3010\u8ffd\u52a0\u60c5\u5831\u3011<\/strong> \u3010Veeva Systems \u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Veeva Forward-looking Statements\u3011<\/strong> ###<\/p>\n \u3010\u5831\u9053\u95a2\u4fc2\u8005\u304b\u3089\u306e\u304a\u554f\u5408\u305b\u5148\u3011<\/strong> AI\u542b\u3080\u6700\u65b0\u88fd\u85acDX\u3092\u7d39\u4ecb\u3001\u5148\u9032\u4e8b\u4f8b10\u793e\u767b\u58c7\u3082<\/p>\n","protected":false},"featured_media":51121,"parent":0,"template":"","class_list":["post-51739","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-type-press-release"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/resources\/51739"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":2,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/resources\/51739\/revisions"}],"predecessor-version":[{"id":51747,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/resources\/51739\/revisions\/51747"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media\/51121"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=51739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n\u7c73\u56fd\u672c\u793e\u3067 Development Cloud \u5168\u88fd\u54c1\u3092\u7d71\u62ec\u3059\u308b Avril England\u3001\u30a2\u30b8\u30a2 R&D and Quality \u30bc\u30cd\u30e9\u30eb\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u306e Chris Shim \u304c\u6765\u65e5\u3057\u3001Veeva Japan \u306e R&D and Quality\u3092\u7d71\u62ec\u3059\u308b\u5cf6\u7530\u5584\u898f\u3068\u3068\u3082\u306b\u3001AI \u306e\u6700\u65b0\u60c5\u5831\u3001\u88fd\u54c1\u306e\u30cf\u30a4\u30e9\u30a4\u30c8\u3084\u30ed\u30fc\u30c9\u30de\u30c3\u30d7\u306b\u3064\u3044\u3066\u304a\u8a71\u3057\u307e\u3059\u3002<\/p>\n
\n2024 \u5e74\u306b Veeva Clinical \uff08 CTMS, eTMF, \u6cbb\u9a13\u5c4a\u306a\u3069\uff09\u3092\u5c0e\u5165\u3057\u305f\u4e2d\u5916\u88fd\u85ac\u69d8\u304c\u3001\u305d\u306e\u7d4c\u9a13\u304b\u3089\u5f97\u3089\u308c\u305f\u5b66\u3073\u3092\u5171\u6709\u3057\u307e\u3059\u3002\u30b0\u30ed\u30fc\u30d0\u30eb\u3067\u306e Roche \u793e\u3068\u306e\u5354\u50cd\u3001\u65e7\u30b7\u30b9\u30c6\u30e0\u304b\u3089\u306e\u79fb\u884c\u3001\u793e\u54e1\u3078\u306e\u6d78\u900f\u3001\u305d\u3057\u3066 IT \u30c1\u30fc\u30e0\u3068\u306e\u9023\u643a\u3068\u3044\u3063\u305f\u69d8\u3005\u306a\u8ab2\u984c\u3092\u3001\u3069\u3046\u4e57\u308a\u8d8a\u3048\u305f\u306e\u304b\u3002\u5c0e\u5165\u30d7\u30ed\u30bb\u30b9\u306b\u304a\u3051\u308b\u300c\u793e\u5185\u306e\u52d5\u304d\u300d\u3068\u300c\u5916\u90e8\u3068\u306e\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u300d\u306e\u4e21\u5074\u9762\u304b\u3089\u3054\u7d39\u4ecb\u9802\u304d\u307e\u3059\u3002<\/p>\n\n
\n\u65e5\u3005\u767a\u751f\u3059\u308bPV\uff08\u533b\u85ac\u54c1\u5b89\u5168\u6027\u60c5\u5831\u7ba1\u7406\uff09\u696d\u52d9\u306e\u52b9\u7387\u5316\u30fb\u6700\u9069\u5316\u306f\u3001\u591a\u304f\u306e\u4f01\u696d\u69d8\u306b\u3068\u3063\u3066\u5927\u304d\u306a\u8ab2\u984c\u306e\uff11\u3064\u3067\u3059\u3002\u672c\u30bb\u30c3\u30b7\u30e7\u30f3\u3067\u306f\u300cVeeva Safety\u300d\u304c AI \u88fd\u54c1\u3084\u4ed6\u306e Veeva \u88fd\u54c1\uff08 Safety-EDC \uff09\u3068\u306e\u9023\u643a\u3092\u901a\u3058\u3001\u3044\u304b\u306b\u3057\u3066\u305d\u306e\u8ab2\u984c\u3092\u89e3\u6c7a\u3057\u3001\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u5411\u4e0a\u3055\u305b\u308b\u304b\u3001\u5177\u4f53\u7684\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u3092\u3054\u7d39\u4ecb\u3057\u307e\u3059\u3002<\/p>\n\n
\n\u958b\u50ac\u65e5\u7a0b\uff1a 2025 \u5e74 10 \u6708 9 \u65e5\uff08\u6728\uff09\u300111:00-18:30
\n\u5834\u6240\uff1a\u30d1\u30ec\u30b9\u30db\u30c6\u30eb\u6771\u4eac\uff08\u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a\u4e38\u306e\u5185 1 \u4e01\u76ee 1 \u2212 1 \uff09
\n\u53c2\u52a0\u5bfe\u8c61\uff1a\u88fd\u85ac\u4f1a\u793e\u306e R&D \u90e8\u9580\u62c5\u5f53\u8005
\n\u53c2\u52a0\u65b9\u6cd5\uff1aVeeva Japan\u30a4\u30d9\u30f3\u30c8\u7279\u8a2d\u30da\u30fc\u30b8\u3088\u308a\u4e8b\u524d\u767b\u9332\uff08\u53c2\u52a0\u7121\u6599\uff09<\/p>\n
\nLinkedIn\u3067Veeva\u306e\u60c5\u5831\u3092\u53d7\u3051\u53d6\u308b\u5834\u5408\u306f\u3053\u3061\u3089\uff1ajp.linkedin.com\/company\/veeva-japan<\/a><\/p>\n
\nVeeva \u306f\u3001\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3001\u30c7\u30fc\u30bf\u3001\u30d3\u30b8\u30cd\u30b9\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u3092\u901a\u3058\u3066\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306b\u7279\u5316\u3057\u305f\u30af\u30e9\u30a6\u30c9\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3001\u512a\u308c\u305f\u88fd\u54c1\u3001\u9867\u5ba2\u306e\u6210\u529f\u306b\u5c3d\u529b\u3057\u3001\u4e16\u754c\u6700\u5927\u306e\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304b\u3089\u65b0\u8208\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u307e\u3067\u30011,500 \u793e\u4ee5\u4e0a\u306b\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u30d1\u30d6\u30ea\u30c3\u30af\u30fb\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30b3\u30fc\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3\u4f01\u696d<\/a>\u3068\u3057\u3066\u3001\u304a\u5ba2\u69d8\u3084\u5f93\u696d\u54e1\u3001\u682a\u4e3b\u3001\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3059\u308b\u696d\u754c\u3092\u542b\u3080\u3001\u3059\u3079\u3066\u306e\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306e\u5229\u76ca\u30d0\u30e9\u30f3\u30b9\u3092\u4fdd\u3064\u3053\u3068\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001www.veeva.com\/jp\/<\/a> \u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements regarding Veeva\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2025, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 32 and 33), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.<\/p>\n
\nVeeva Japan\u682a\u5f0f\u4f1a\u793e
\n\u5e83\u5831\u30c1\u30fc\u30e0
\npr.jp@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"